Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Early Parkinson's Disease

被引：0

作者：

Nausieda, Paul ^{[1
]}

Rudzinska, Monika ^{[2
]}

Kell, Sherron ^{[3
]}

O'Connell, Martin ^{[3
]}

Hsu, Ann ^{[3
]}

Gupta, Suneel ^{[3
]}

机构：

[1] Aurora Sinai Med Ctr, Milwaukee, WI USA

[2] Jagiellonian Uniwers, Krakow, Poland

[3] Impax Pharmaceut, Hayward, CA USA

来源：

NEUROLOGY | 2013年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P01064

引用

页数：2

共 50 条

[1] Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Motor Fluctuations in Advanced Parkinson's Disease
Ellenbogen, Aaron
Nausieda, Paul
Pourcher, Emmanuelle
Rudzinska, Monika
Kell, Sherron
O'Connell, Martin
Hsu, Ann
Gupta, Suneel
NEUROLOGY, 2013, 80
[2] Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease
Mueller, Thomas
Moehr, Jan-Dominique
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2063 - 2071
[3] Efficacy and Safety of IPX066, a Carbidopa-Levodopa, Extended-Release Formulation, in Early Parkinson's Disease
Pahwa, Rajesh
Elllenbogen, Aaron
Kell, Sherron
O'Conell, Martin
Hauser, Robert
Fahn, Stanley
Jankovic, Joseph
Pourcher, Emmanuelle
Hsu, Ann
Gupta, Suneel
ANNALS OF NEUROLOGY, 2013, 74 : S47 - S47
[4] Safety of IPX066, an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease
Kestenbaum, Meir
Fahn, Stanley
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 761 - 767
[5] IPX066: a novel carbidopa-levodopa extended-release formulation
Hauser, Robert A.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (02) : 133 - 140
[6] Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson's disease patients: Dosing patterns
Morgan, J.
Stacy, M.
Rubens, R.
Khanna, S.
Gupta, S.
MOVEMENT DISORDERS, 2016, 31 : S659 - S659
[7] The effects of gender on adverse event reporting in Parkinson's disease patients treated with IPX066 extended-release carbidopa-levodopa capsules
Kell, S.
O'Connell, M.
Hsu, A.
Silver, D.
Elmer, L.
Gupta, S.
MOVEMENT DISORDERS, 2013, 28 : S148 - S148
[8] Efficacy of IPX066, an extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease patients with troublesome dyskinesia
Dhall, R.
Struck, L.
Rubens, R.
Shah, V.
Gupta, S.
MOVEMENT DISORDERS, 2015, 30 : S79 - S80
[9] The effects of weight on adverse event reporting in Parkinson's disease patients treated with IPX066 extended-release carbidopa-levodopa capsules
Kell, S.
O'Connell, M.
Hsu, A.
Silver, D.
Elmer, L.
Gupta, S.
MOVEMENT DISORDERS, 2013, 28 : S146 - S147
[10] Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease
Mao, Zhongping Lily
Modi, Nishit B.
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 974 - 982

← 1 2 3 4 5 →